Follow
Jens Rauch
Jens Rauch
Assistant Professor and Group Leader, Systems Biology Ireland, University College Dublin
Verified email at ucd.ie
Title
Cited by
Cited by
Year
Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity
S Lee, J Rauch, W Kolch
International journal of molecular sciences 21 (3), 1102, 2020
5622020
Raf family kinases: old dogs have learned new tricks
D Matallanas, M Birtwistle, D Romano, A Zebisch, J Rauch, ...
Genes & cancer 2 (3), 232-260, 2011
4562011
Evaluating strategies to normalise biological replicates of Western blot data
A Degasperi, MR Birtwistle, N Volinsky, J Rauch, W Kolch, ...
PloS one 9 (1), e87293, 2014
2272014
The secret life of kinases: functions beyond catalysis
J Rauch, N Volinsky, D Romano, W Kolch
Cell communication and signaling 9, 1-28, 2011
2142011
Big signals from small particles: regulation of cell signaling pathways by nanoparticles
J Rauch, W Kolch, S Laurent, M Mahmoudi
Chemical reviews 113 (5), 3391-3406, 2013
1922013
Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development
A Shilo, VB Hur, P Denichenko, I Stein, E Pikarsky, J Rauch, W Kolch, ...
Rna 20 (4), 505-515, 2014
1142014
Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription
J Rauch, E O'Neill, B Mack, C Matthias, M Munz, W Kolch, O Gires
Cancer research 70 (4), 1679-1688, 2010
1112010
Emergence of bimodal cell population responses from the interplay between analog single-cell signaling and protein expression noise
MR Birtwistle, J Rauch, A Kiyatkin, E Aksamitiene, M Dobrzyński, JB Hoek, ...
BMC systems biology 6, 1-12, 2012
962012
Allogenic antibody-mediated identification of head and neck cancer antigens
J Rauch, M Ahlemann, M Schaffrik, B Mack, S Ertongur, M Andratschke, ...
Biochemical and biophysical research communications 323 (1), 156-162, 2004
932004
Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology
O Gires, M Münz, M Schaffrik, C Kieu, J Rauch, M Ahlemann, D Eberle, ...
Cellular and Molecular Life Sciences CMLS 61, 1198-1207, 2004
872004
HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways
J Farrell, C Kelly, J Rauch, K Kida, A Garcia-Munoz, N Monsefi, ...
Journal of proteome research 13 (6), 2874-2886, 2014
792014
c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway
J Rauch, K Moran-Jones, V Albrecht, T Schwarzl, K Hunter, O Gires, ...
Cancer research 71 (13), 4664-4674, 2011
792011
The complexities and versatility of the RAS-to-ERK signalling system in normal and cancer cells
D Fey, D Matallanas, J Rauch, OS Rukhlenko, BN Kholodenko
Seminars in cell & developmental biology 58, 96-107, 2016
762016
CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck
O Gires, B Mack, J Rauch, C Matthias
Biochemical and biophysical research communications 343 (1), 252-259, 2006
682006
Physiological Temperature Has a Crucial Role in Amyloid Beta in the Absence and Presence of Hydrophobic and Hydrophilic Nanoparticles
M Ghavami, M Rezaei, R Ejtehadi, M Lotfi, MA Shokrgozar, B Abd Emamy, ...
ACS Chemical Neuroscience 4, 375-378, 2013
662013
Dissecting RAF inhibitor resistance by structure-based modeling reveals ways to overcome oncogenic RAS signaling
OS Rukhlenko, F Khorsand, A Krstic, J Rozanc, LG Alexopoulos, N Rauch, ...
Cell systems 7 (2), 161-179. e14, 2018
592018
Cell type-specific activation of AKT and ERK signaling pathways by small negatively-charged magnetic nanoparticles
J Rauch, W Kolch, M Mahmoudi
Scientific reports 2 (1), 868, 2012
542012
Molecular characterization of the tumor-associated antigen AAA-TOB3
M Schaffrik, B Mack, C Matthias, J Rauch, O Gires
Cellular and Molecular Life Sciences CMLS 63, 2162-2174, 2006
392006
MultiBac: from protein complex structures to synthetic viral nanosystems
M Pelosse, H Crocker, B Gorda, P Lemaire, I Rauch, Jens and Berger
BMC Biology 15 (1), 2581, 2017
352017
SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification
J Rauch, O Gires
PROTEOMICS–Clinical Applications 2 (3), 355-371, 2008
302008
The system can't perform the operation now. Try again later.
Articles 1–20